Agile Study

  • Research type

    Research Study

  • Full title

    Multicenter retrospective observational study to assess the clinical performance and safety profile of AGILE NAIL in paediatric patients who have suffered femoral shaft and subtrochanteric fractures, have performed prophylactic nailing of impending pathologic fractures or have undergone fixation of femurs that have been surgically prepared for deformity correction: AGILE Study

  • IRAS ID

    335551

  • Contact name

    Patrick Foster

  • Contact email

    patrick.foster@nhs.net

  • Sponsor organisation

    Orthofix S.r.l.

  • Duration of Study in the UK

    1 years, 2 months, 28 days

  • Research summary

    The study will be conducted in two investigational sites, one in France and one in United Kingdom, both experienced in the treatment of paediatric patients with femoral shaft and subtrochanteric fractures and deformity correction procedures, where the usage of AGILE NAIL (known as AGILE) was part of the normal clinical practice.

    Investigators at both study sites will provide data for a maximum of 45 patients meeting inclusion and exclusion criteria (Considering a drop-out or a non-evaluable rate of 10% of the procedures) that will contribute for approximately 45 procedures in which AGILE was used.
    No diagnostic or therapeutic intervention outside of routine clinical practice will be applied. The study has been designed to analyse medical records of patients where study data was collected as part of their routine clinical practice. Therefore, patients will be retrospectively enrolled in the study.

    Patients who have undergone AGILE implantation from 04/2018 to 12/2022 are considered for the study. The observation period of study subjects will comprise from surgery until the last follow up visit available.

    Medical records of the participating sites are expected to contain all the required information. No study visit will be required.

  • REC name

    West of Scotland REC 5

  • REC reference

    24/WS/0036

  • Date of REC Opinion

    30 Apr 2024

  • REC opinion

    Further Information Favourable Opinion